1. Home
  2. HPI vs ALT Comparison

HPI vs ALT Comparison

Compare HPI & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HPI
  • ALT
  • Stock Information
  • Founded
  • HPI 2002
  • ALT 1997
  • Country
  • HPI United States
  • ALT United States
  • Employees
  • HPI N/A
  • ALT N/A
  • Industry
  • HPI Trusts Except Educational Religious and Charitable
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • HPI Finance
  • ALT Health Care
  • Exchange
  • HPI Nasdaq
  • ALT Nasdaq
  • Market Cap
  • HPI 505.3M
  • ALT 457.0M
  • IPO Year
  • HPI N/A
  • ALT N/A
  • Fundamental
  • Price
  • HPI $17.46
  • ALT $7.61
  • Analyst Decision
  • HPI
  • ALT Buy
  • Analyst Count
  • HPI 0
  • ALT 7
  • Target Price
  • HPI N/A
  • ALT $20.00
  • AVG Volume (30 Days)
  • HPI 64.7K
  • ALT 3.7M
  • Earning Date
  • HPI 01-01-0001
  • ALT 11-12-2024
  • Dividend Yield
  • HPI 8.97%
  • ALT N/A
  • EPS Growth
  • HPI N/A
  • ALT N/A
  • EPS
  • HPI N/A
  • ALT N/A
  • Revenue
  • HPI N/A
  • ALT $52,000.00
  • Revenue This Year
  • HPI N/A
  • ALT N/A
  • Revenue Next Year
  • HPI N/A
  • ALT N/A
  • P/E Ratio
  • HPI N/A
  • ALT N/A
  • Revenue Growth
  • HPI N/A
  • ALT N/A
  • 52 Week Low
  • HPI $12.85
  • ALT $2.38
  • 52 Week High
  • HPI $16.83
  • ALT $14.84
  • Technical
  • Relative Strength Index (RSI)
  • HPI 35.40
  • ALT 52.04
  • Support Level
  • HPI $17.61
  • ALT $6.92
  • Resistance Level
  • HPI $18.39
  • ALT $11.16
  • Average True Range (ATR)
  • HPI 0.23
  • ALT 0.85
  • MACD
  • HPI -0.05
  • ALT 0.13
  • Stochastic Oscillator
  • HPI 7.92
  • ALT 24.63

About HPI John Hancock Preferred Income Fund of Beneficial Interest

John Hancock Preferred Income Fund is a closed-end, diversified management investment company. Its primary investment objective is to provide a high level of current income consistent with preservation of capital. The fund's secondary investment objective is to provide growth of capital to the extent consistent with its primary investment objective. It seeks to achieve its investment objectives by investing in securities that may be undervalued relative to similar securities in the marketplace. The fund's principal investment strategies include investing a majority of its assets in preferred stocks and other preferred securities. Its portfolio composition consists of U.S preferred securities, common stocks, foreign preferred securities, corporate bonds, and short-term investments.

About ALT Altimmune Inc.

Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.

Share on Social Networks: